Leo Brokerage’s iShares Biotechnology ETF IBB Stock Holding History

Leo Brokerage’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$336K	Buy	2,648 +82	+3%	+$10.7K	0.04%	229
2023 Q1	$331K	Buy	+2,566	New	+$336K	0.05%	218
2022 Q2	–	Sell	-2,463	Closed	-$321K	–	207
2022 Q1	$321K	Buy	+2,463	New	+$321K	0.05%	185
2021 Q3	$2.65M	Buy	16,413 +355	+2%	+$59.7K	0.49%	35
2021 Q2	$2.63M	Buy	16,058 +1,233	+8%	+$190K	0.53%	38
2021 Q1	$2.23M	Buy	14,825 +1,288	+10%	+$205K	0.63%	38
2020 Q4	$2.05M	Buy	13,537 +2,136	+19%	+$305K	0.66%	35
2020 Q3	$1.56M	Buy	+11,401	New	+$1.55M	0.64%	29

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Leo Brokerage's IBB Position: Q2 2023 in Review

Leo Brokerage increased its iShares Biotechnology ETF (IBB) stake by 3.2% in Q2 2023, buying an estimated $10.7K and bringing the position to 2,648 shares worth $336K. The position accounts for 0.04% of the portfolio, ranked #229.

Leo Brokerage first reported a position in IBB in Q3 2020 and has held it in 8 quarters since. The position peaked at $2.65M in Q3 2021. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

Leo Brokerage held 2,648 shares of iShares Biotechnology ETF worth $336K as of Q2 2023.
Leo Brokerage bought 82 iShares Biotechnology ETF shares in Q2 2023, an estimated $10.7K.
iShares Biotechnology ETF made up 0.04% of Leo Brokerage's portfolio in Q2 2023, its #229 holding.
Leo Brokerage first reported a position in iShares Biotechnology ETF in Q3 2020 and has held it in 8 quarters since.
Leo Brokerage's iShares Biotechnology ETF position peaked at $2.65M in Q3 2021.
843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on Leo Brokerage's 13F filing for Q2 2023, filed 25 Jul 2023.